ClinicalTrials.gg
CompletedNCT05972187IEQ-HUMUpdated Mar 24, 2025

The Effect of IEQ on Cognition and Health

An interventional study of Temperature and Humidity in Environmental Exposure, Temperature Change, Body and Condition, sponsored by Maastricht University Medical Center. Completed at 1 site in Netherlands. Open to participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-24.

Sponsored by Maastricht University Medical Center · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Not applicable
Ages
20 Years to 40 Years
Sex
All
01

Study summary

The goal of this study is to learn about the effect of heat and humidity on cognition and health. The main question[s] it aims to answer are:

type of study: interventional participant population: 20-40years, both gender, healthy Participants will be exposed for 4 different sessions of 8 hours at a time, to 32˚ C or 25˚ C in combination with relative humidity of 30 %RH or 70 %RH.

Read the detailed description

Overall, the project aims to evaluate the effects of high vs. neutral temperature (32˚ C vs. 25˚ C) in combination with high vs. low humidity (30 %RH vs. 70 %RH) on cognition, for longer exposure duration (8 hours). Deviations from the personal comfort zones are expected to affect both subjective feelings and physiological parameters. Therefore, the following parameters will be included: cognition, environmental perception, energy expenditure, body temperatures.

Main research question and primary objective:

What is the impact of being exposed for 8 hours to a high humidity (RH 70%) versus low humidity (RH 30%) on cognitive performance of individuals if the room temperature is 25ºC or 32ºC?

This leads to the following hypotheses:

  • Exposure to an indoor high relative humidity (RH 70%) at a warm temperature (32ºC) of a long duration (8 hours) reduces the composite score, speed and accuracy of cognitive performance compared to an exposure to a low RH (30%) at the same temperature (32ºC) due to the humidity.
  • An exposure to an indoor high relative humidity (RH 70%) at a neutral temperature (25ºC) of a long duration (8 hours) would reduce the composite score, speed and accuracy of cognitive performance compared to an exposure to a low RH (30%) at a neutral temperature (25 ºC) due to previous literature for humidity influences at neutral temperatures.

Secondary research question and secondary objective:

What is the effect of high vs. neutral temperature (32˚ C vs. 25˚ C) in combination with high vs. low humidity (30 %RH vs. 70 %RH) on physiological responses, environmental perception, decision making, and bias behaviour?

This leads to the following hypotheses:

  1. Does an 8 hour exposure to an elevated concentration of indoor humidity lead to an increase in energy expenditure and/or a greater difference in proximal and distal blood flow and skin temperature gradients compared to a lower indoor humidity for each of the temperature settings?
  2. What are the effects of high humidity on substrate oxidation, blood pressure, heart rate variability, proximal and distal skin temperature, risk behavior and decision-making responses of individuals?
  3. What are the effects of higher humidity on environmental perception (thermal, air quality, moisture/wetness) comfort, perception, and sensation?

    • An exposure to an indoor high relative humidity (RH 70%) at a warm temperature (32ºC) of a long duration (8 hours) reduces the composite score, speed and accuracy of cognitive performance compared to an exposure to a high RH (70%) at a neutral temperature (25 ºC) due to the humidity and temperature.
    • An exposure to an indoor low relative humidity (RH 30%) at a warm temperature (32ºC) of a long duration (8 hours) would reduce the composite score, speed and accuracy of cognitive performance compared to an exposure to the same low RH (30%) at a neutral temperature (25 ºC) due to the temperature.

Exploratory research question and objective:

What is the interaction effect of high vs. neutral temperature (32˚ C vs. 25˚ C) in combination with high vs. low humidity (30 %RH vs. 70 %RH) on cognitive performance, physiological responses, environmental perception, decision making, and bias behaviour?

02

Conditions studied

  • Environmental Exposure
  • Temperature Change, Body
  • Condition
  • Healthy

Keywords

  • Temperature
  • Humidity
  • Thermoregulation
  • Cognition
  • Health
03

In context

Body Temperature Changes

97 studies on the registry are indexed under Body Temperature Changes; 20 are open to participants now.

This study's enrollment of 22 is below the median of 40 across 68 interventional studies indexed under Body Temperature Changes.

Browse Body Temperature Changes studies →

Lead sponsor

Maastricht University Medical Center is the lead sponsor of 853 studies on the registry; 114 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • between 18.5-26 kg/m2
  • Age between 20-40 years
  • Proficient with the English language in both verbal and written form
  • Healthy; no illness or disease or prescribed medication within the last 3 months
  • Steady dietary and sleeping habits
  • Regularly physically active (i.e., regularly active but less than 3 times a week for less than 2 hours per session at moderate intensity)
  • Non-smoker or person who quit smoking more than five years ago
  • Reside in the Netherlands (or surrounding countries) for at least 6 months

Exclusion criteria

Exclusion Criteria:

  • Subjects with cardiac problems and cardiovascular diseases, such as angina pectoris, cardiac infarction, and arrhythmias
  • Subjects with any medical condition requiring treatment and/or medication (except oral ) that might interfere with the investigated parameters E.g., Extreme chronotype, colour blindness, epilepsy
  • Subjects with a disorder or disease (Parkinson, Attention Deficit Hyperactivity Disorder (ADHD), Alzheimer, diabetes, cardiovascular disorder, respiratory impairments (for example asthma), hypertension, obesity, or any other condition that can impair the lung function), or Raynaud's phenomenon
  • Subjects with abnormal diet and sleeping patters and/or abnormal body weight (weight gain or loss >3kg in the past month)
  • Subjects who recently participated in other interventional biomedical study within 1 month prior to screening visit
  • Subjects, who do not want to be informed about unexpected medical findings, or do not wish that their treating physician will be informed, cannot participate in this study
  • Subjects with previous covid infection in the past 3 months or any subject with persistent long covid symptoms that may have caused ongoing loss of or altered sense of smell
  • Subjects who had severely altered sleep patterns in the past year
  • Subjects employed with night shift work within the past year
  • Subjects who consume more than two standard drinks of alcohol per day
  • Subjects who consume more than two standard drinks of coffee per day
  • Subjects who are pregnant
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    Temperature and Humidity

    32C or 25C and 30%RH or 70%RH

    Other: Temperature and Humidity

Interventions

  • OtherTemperature and Humidity

    Temperature and Humidity of room changed

06

What researchers measure

Primary outcomes

  1. Cognition

    Using a tablet based cognitive test battery

    Time frame: 1 month

Secondary outcomes

  1. Heart Rate (bpm)

    Heart Rate measured using Polar heart rate belt in (bpm) with RR and ECG data extracted

    Time frame: 1 month

  2. Blood pressure (mmHg)

    Blood pressure - both systolic and diastolic pressures measured hourly using an automated blood pressure monitor and cuff

    Time frame: 1 month

  3. Metabolic Rate (ml O2//min/kg)

    Metabolic rates measured through whole room calorimetry

    Time frame: 1 month

  4. Skin Temperature (C)

    Skin temperature measured using thermochron (ibuttons) at multiple sites

    Time frame: 1 month

  5. Body Core Temperature (C)

    Core Temperature measured via telemetric pill ingested in the morning

    Time frame: 1 month

Other outcomes

  1. Room Temperature (C)

    Environmental measures are measured continuously using temperature specific sensors in the room

    Time frame: 1 month

  2. Humidity (%)

    Environmental measures are measured continuously using humidity specific sensors in the room

    Time frame: 1 month

07

Study locations

1 site
  • Maastricht University
    Maastricht, Netherlands
08

References and documents

Individual participant data

Plan to share: Yes — If requested raw data will be provided.

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: Ongoing, depends on the request.

Access criteria: Official request made stating the purpose of use for the data. Only individuals that consent to their data to be used in further analysis will be shared.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05972187
Responsible party
Sponsor
First posted
Aug 2, 2023
Start date
Jun 18, 2023
Primary completion
May 7, 2024
Completion
May 7, 2024
Last update
Mar 24, 2025

Study contacts

Guy Plasqui, PHD
principal investigator · Maastricht University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion